That's why General Motors' (GM) Chevy Volt won top marks for safety in small cars.
The Volt was named "Top Safety Pick Plus" Wednesday by the Insurance Institute for Highway Safety, because besides earning an "acceptable" rating in an actual crash test, the hybrid electric vehicle also has an optional forward collision warning system. It was the only car out of the 12 models tested to have the crash prevention technology.
IIHS submitted twelve small vehicles through a tough crash test called the "small overlap front test." In the test, 25 percent of the vehicle's front end on the driver's side strikes a rigid barrier at 40 miles per hour. It simulates a common head-on collision, when only part of the bumper connects with another car, telephone pole, or tree.
Top 5 Undervalued Companies To Invest In 2015: Melrose Industries PLC (MLSPF)
Melrose Industries PLC acquires manufacturing businesses and improves them. The Company operates in four divisions: Energy, Lifting, Other Industrial and Elster. The Energy division is a supplier of turbogenerators, other electricity generating machinery, switchgear, transformers and power infrastructure equipment. Its products consist of power management and excitation systems; power and system transformers, and aftermarket servicing. Lifting division is a supplier of lifting fittings, blocks and custom engineered material handling products and supplier for wire and wire rope. Other Industrial division has manufacturing businesses across the housing, construction and scrap processing sectors. Elster is a provider of gas control equipment and related communications, gas, electricity and water meters and software solutions. In January 2014, the Company disposed Harris Waste Management Group, Inc. to Avis Industrial Corporation. Advisors' Opinion:- [By Roland Head]
Today, I'm going to take a look at�Melrose Industries� (LSE: MRO ) (NASDAQOTH: MLSPF ) , an unusual company which specialises in turning around manufacturing businesses, before selling them on. Melrose's current portfolio of businesses contains German utility meter maker Elster, Brush Turbo Generators and Marelli Motori, which make electric motors and generators, and Bridon, which makes rope and wire products used in the oil and gas industry.
5 Best Safest Stocks To Buy For 2014: Coronado Biosciences Inc (CNDO)
Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company�� two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn�� disease (Crohn��), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.
TSO
TSO is the microscopic eggs of a parasitic helminth, or worm, that is found in pigs. In September 2011, the Company filed an Investigational New Drug Application (IND) with the United States Food and Drug Administration (FDA) and it initiated a single dose, dose escalation study in patients with Crohn�� in February 2012. The Phase 1 clinical trial was a multi-center, sequential dose-escalation, double-blind, placebo-controlled study, the primary objective of which was to evaluate the safety and tolerability of TSO. The trial enrolled 36 patients with Crohn�� ranging in age from 20 to 54 with an equal distribution of male and female patients in three single dose cohorts of orally administered 500, 2500 and 7500 ova. Each cohort had 12 patients, with nine patients receiving TSO and three receiving placebo.
CNDO-109
CNDO-109 is a lysate (disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor NK cells. CTV-1 is a leukemic cell line recently re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company has worldwide rights to develop and commercialize CNDO-109 activated NK cells for the treatment of cancer fro! m UCLB. In February 2012, the Company submitted an IND for the CNDO-109 activated NK cell product in the United States. The treatment of patients with CNDO-109 activated NK cells involves several steps. The activated NK cells are infused into the patient after resting NK cells are incubated with CNDO-109 for at least eight hours. Preparation of CNDO-109 activated NK cells takes about 24 hours from start to finish.
The Company competes with Centocor Ortho Biotech Inc.�� Remicade , UCB S.A.�� Cimzia, Abbott Laboratories��Humira, Biogen Idec�� Avonex, Bayer Healthcare Pharmaceuticals��Betaseron, Teva Pharmaceuticals Industries, Ltd.�� Copaxone and Novartis AG�� Gilenya.
Advisors' Opinion:- [By James E. Brumley]
The last few weeks haven't been particularly encouraging for Crohn's disease sufferers. In August, GlaxoSmithKline (NYSE: GSK) and ChemoCentryx (NASDAQ:CCXI) reported that a jointly-developed Crohn's drug, vercirnon, had failed to meet its late-stage trial endpoints. Though the in-development drug isn't dead in the water (GSK and CCXI could rework the drug, the testing regimen, or use it for other indications), it doesn't look good. Then this month - just a few days ago - Coronado Biosciences Inc. (NASDAQ:CNDO) reported that its Phase 3 trials of Crohn's disease drug TSO had also failed to meet its primary endpoints as well. Like vercirnon, CNDO isn't completely out of luck here with the treatment, but forging ahead with further development of the treatment is grasping at straws. Crohn's sufferers don't need to give up home just yet, however - TNI Biotech Inc. (OTCMKTS:TNIB) appears to have a Crohn's treatment that works, and should be able to sidestep the problems that plagued ChemoCentryx, GlaxoSmithKline, and Coronado Biosciences.
- [By CRWE]
Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, reported that it has filed a registration statement with the Securities and Exchange Commission for a proposed public offering of 2,000,000 shares of its common stock. All shares proposed to be included in the offering will be sold by the company.
- [By Roberto Pedone]
One under-$10 biopharmaceutical player that's quickly moving within range of triggering a major breakout trade is Coronado Biosciences (CNDO), which is focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. This stock has been hit hard by the bears in 2013, with shares off by 43%.
If you take a look at the chart for Coronado Biosciences, you'll notice that this stock has been uptrending strong since it double bottomed in November, with shares moving higher from its low of $1.25 to its intraday high of $2.58 a share. During that uptrend, shares of CNDO have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CNDO within range of triggering a major breakout trade.
Traders should now look for long-biased trades in CNDO if it manages to break out above some key overhead resistance at $2.70 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.97 million shares. If that breakout hits soon, then CNDO will set up to re-fill some of its previous gap down zone from October that started near $7 a share. Some possible upside targets if CNDO gets into that gap with volume are $4 to $5 a share.
Traders can look to buy CNDO off any weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support at $2 a share. One can also buy CNDO off strength once it takes out $2.70 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
5 Best Safest Stocks To Buy For 2014: Honeywell International Inc.(HON)
Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. Its Aerospace segment provides turbine propulsion engines, auxiliary power units, environmental control and electric power systems, engine systems and accessories, avionic systems, aircraft lighting, inertial sensors, control products, space products and subsystems, and landing products for aircraft manufacturers, airlines, business and general aviation, military, space, and airport operations, as well as offers management and technical, logistics, aircraft wheels and brakes and repair, and overhaul services. The company?s Automation and Control Solutions segment provides environmental and combustion controls, and sensing controls; security and life safety products and services; scanning and mobility products; process automation products and solutions; and building solutions and services for homes, buildings, and industrial facilities. Its Specialty Materials segment prov ides resins and chemicals; hydrofluoric acid; fluorocarbons; fluorine specialties; nuclear services; performance chemicals; chemical processing sealants; fibers and composites; specialty films and additives; imaging and electronic chemicals; semiconductor materials and services; catalysts, adsorbents, and specialties; and renewable fuels and chemicals. It offers these products for refining, petrochemical, automotive, healthcare, agricultural, packaging, refrigeration, appliance, housing, semiconductor, wax, and adhesives segments. This segment also provides process technology and equipment for the petroleum refining, and petrochemical and gas processing industries. The company?s Transportation Systems segment provides charge-air systems; thermal systems; filters, spark plugs, electronic components, and car care products; and brake hard parts and other friction materials for passenger cars and commercial vehicles. The company was founded in 1920 and is headquartered in Morris Township, New Jersey.
Advisors' Opinion:- [By Rich Smith]
Honeywell's (NYSE: HON ) earnings report Friday was quickly overshadowed by news reports that one of its devices, an emergency locator transmitter, may be linked to the on-ground fire that broke out in an Ethiopian Airlines-operated Boeing (NYSE: BA ) 787 at Heathrow Airport last week.
- [By Lauren Pollock]
Honeywell International Inc.(HON) gave a cautious profit outlook for 2014, while the maker of aerospace, building control and safety products offered a revenue target that fell short of Wall Street’s expectations.
- [By Rich Smith]
The Department of Defense awarded a bit more than $235 million worth of contracts Wednesday, with three big publicly traded companies accounting for more than a quarter of the total contract value awarded.
Lockheed Martin (NYSE: LMT ) won a $39 million contract exercising a firm-fixed-price option to produce Block 2 Surface Electronic Warfare Improvement Program (SEWIP) systems at low-rate initial production rates.�The SEWIP program aims to upgrade the U.S. Navy's current AN/SLQ-32(V) Electronic Warfare System to improve the performance of antennae and receivers. Work on this contract should be complete by September 2014. Raytheon (NYSE: RTN ) was awarded a $14.6 million modification to a previously awarded contract to do phase II design work on the Joint Precision Approach and Landing System (JPALS), assessing, documenting, and implementing design modifications to make the JPALS Increment 1A Ship system easier to maintain.�JPALS is a project to make aircraft landing systems that run on GPS more robust, and harder for opposing forces to jam. This contract runs through December 2013. Honeywell (NYSE: HON ) won a $9 million�contract to supply 121 advanced multipurpose displays for installation aboard Navy F/A-18E/F fighter jets and EA-18G electronic warfare aircraft.�Delivery and installation should be complete by January 2015.link
- [By Patrick Morris]
Honeywell (NYSE: HON ) announced today that Federal-Mogul (NASDAQ: FDML ) has agreed to purchase portions of its brake friction business in the automotive and industrial sectors for $155 million. Honeywell has more than 2,000 global employees in its Friction Material business, which is headquartered in Germany.�
5 Best Safest Stocks To Buy For 2014: ITonis Inc (ITNS)
ITonis Inc., incorporated on July 5, 2005, operates as a holding company. The Company focuses to purchase entrepreneurial companies that have established themselves, or are expected to establish themselves in various markets.
The Company invests in small growth entrepreneurial companies. In May 2011, the Company acquired Performance Mortgage Group, Inc., as a wholly owned subsidiary.
Advisors' Opinion:- [By Peter Graham]
What�� the Catch With MyEcheck Inc? According to various disclosures, transactions of $500 and $2k have or will occur to mention MyEcheck Inc in various investment newsletters. The most recent news for MyEcheck Inc is not so recent as it dates from last April and was an announcement that the company would license its proprietary system to other operators for a share of their transaction revenue on the system with the CEO pointing out: ��n addition to our processing revenue, we will have licensing revenue that will exceed our processing revenue in a relatively short period of time." However, a quick look at MyEcheck Inc�� financials reveals revenues of $3k (most recent reported quarter), zero, zero and zero for the past four quarters along with net income of $387k (most recent reported quarter) and net losses of $8k, $35k and $14k. At the end of last June, MyEcheck Inc had no cash to cover $804k in current liabilities. So maybe investor will want to wait for evidence of licensing and processing revenue to materialize.
ITonis Inc (OTCMKTS: ITNS) Recently Announced Its First OrderSmall cap ITonis Inc is an Orange County, California based holding company established in 2005 that's is currently undergoing a company-wide transformation to embark upon an aggressive acquisition plan to purchase high growth entrepreneurial companies that have established themselves, or are expected to establish themselves as leaders in various market niches. On Friday, ITonis Inc fell 9.09% to $0.003 for a market cap of $2.56 million plus ITNS is down 80.3% over the past year and down 50% over the past five years according to Google Finance.
No comments:
Post a Comment